Next Year’s Advocacy Impact Story Starts Now
- by: Rx4good |
September 28, 2026 - Categories:
Good4Patients: Timely Perspective from Rx4good
The 4-Second Skim
- Impact reports often come together at year-end, after busy teams have spent the year responding to changing priorities and immediate needs.
- By then, teams may have plenty of activity to report, but little evidence of what changed.
- The answer is to begin earlier: learn what patients and partners need, establish a baseline, and keep measuring and learning as the work unfolds.
Despite the best-laid plans, too many impact reports begin at year-end, when teams juggling year-end deadlines must gather activities, aggregate attendance figures, partner feedback, and program highlights. By then, the most important question is often hard to answer: What did we change?
Our experience has shown time and again that the strongest reports begin much earlier – 12 months earlier, when teams are planning the year ahead. When internal stakeholders align on what they want to change, how they will make that change, and how they will know it has occurred, measurement is simply part of the work. It guides decisions during the year and makes the value of advocacy apparent and easy to explain.
In fact, the most meaningful impact reports are relevant across teams and functions, adding useful dimension to what patients are experiencing in the real world. Getting it right takes time, buy-in across the company, and a little budget. However, such advance preparation consistently leads to relevant and actionable results, in our experience.
Read on for five tips for measuring change:
1. Start with the change you want to create
Meetings, councils, educational materials, and partner programs all matter – they should be tracked and counted. But we all know that a list of activities alone does not show the value of patient advocacy work. Start by asking what is going to be different for patients, partners, or the company. The answer might involve better understanding, fewer barriers, stronger relationships, more useful patient input, or better-informed decisions.
An important way Rx4good helps teams is to connect each goal to the right evidence. A program focused on education looks at what and how people understand. A program intended to inform company decisions records where patient input was considered and the impact it had. A partnership effort looks at the strength and continuity of the relationship, along with what partners were able to accomplish, not the transactions that occurred.
2. Know where you are starting
Results only make sense in context. Reaching 500 people may sound encouraging, but it does not show whether awareness improved, the right people were reached, or a meaningful gap was addressed. Having a baseline – such as current knowledge, attitudes, barriers, level of engagement, or partner reach – helps teams set realistic goals and tailor their reporting to the challenges they are trying to solve.
Useful starting points may already exist in surveys, partner feedback, prior-year results, published research, or other data the company can access. If the key information is missing, a focused survey or set of interviews can fill the gap. This step can also prevent teams from investing in more awareness when the larger problem is trust, access, or the ability to act.
For one client, we tapped patient and caregiver input to establish a baseline of what people understood when biomarker results first appeared in their records – and where confusion began. That starting point gave the team a clear remit for their education initiative and a way to measure whether understanding improved.
3. Track progress before the final outcome
Changes in policy, trial participation, testing, access, or health behavior can take years and depend on many factors. Teams still want to see how a program is moving and in what direction. Early progress – leading indicators – may include greater understanding, fewer misconceptions, stronger confidence, more trust, or a greater willingness to take the next step.
For a clinical trial education program, for example, enrollment may not change right away. Earlier signs can include better understanding of the study, fewer concerns based on misinformation, greater willingness to ask a physician about eligibility, or more confidence among advocacy partners discussing the trial. Reporting these leading indicators is a great way to keep partners, leadership, and other key stakeholders engaged for longer-term outcomes.
4. Build measurement into the work
Keep data collection simple: a short question before and after a session, a consistent meeting debrief, a record of where patient input was shared, a partner follow-up, or a quarterly review. A few well-chosen questions asked consistently and in a timely manner are more useful than a long survey completed too late.
When a global program involving 80 patient advocates needed a clearer way to track its impact, Rx4good made measurement part of the ongoing work. We brought together colleagues from across the company, reviewed how teams were recording patient input, identified gaps, and created a shared measurement framework and practical resources. This gave teams a consistent way to document where patient input shaped trials and other decisions throughout the product lifecycle.
5. Learn with advocacy partners
Advocacy partners can often see what company reports cannot: the questions patients keep asking after an education program, the reasons people decline a referral or trial screening, which materials people use, and which patients are still missing from the conversation. We recommend asking partners what they are hearing, what they already track, and what would help them. Then share the findings back and decide together what should change.
In one Rx4good engagement, a survey and interviews with a sub-sample provided a company with a better understanding of mistrust in a disease community. Bringing community leaders into the process to interpret the findings, add context, and shape the response ensured the relevance and actionability of the findings. Advocate guidance informed principles for funding, communications, executive involvement, and even the company’s long-term presence.
Telling the full story of impact
A strong impact report connects the original need to the work and the result. It shows the baseline, the people and resources involved, what the team and its partners did, and what happened as a result. That means including outputs, such as people reached or resources created, alongside outcomes, such as actions taken, beliefs changed, barriers reduced, or patient input used in a company decision.
Impact reporting is also meant to explain what the team learned, where progress fell short, and what needs to happen next. When these expectations and their corresponding measures are set before the work begins and reviewed throughout the year, the final report shows credible progress and helps shape the next year’s priorities.
Rx4good helps patient advocacy teams build practical approaches to planning, measurement, and impact reporting – whether that means starting fresh or strengthening an existing program. If you want next year’s impact story to be clearer, more useful, and easier to support with evidence, let’s talk through where to begin.
